MedBright AI Investments Inc. announced that the Limmi Disease Insights Platform is now being used in hospitals with an initial focus on kidney stone disease recurrence. Limmi is a key investment in Medbright?s AI Healthcare portfolio. UC San Diego Health is the first site that is utilizing Limmi?s Disease Insights Platform in a hospital setting.

Limmi's Disease Insights Platform has been meticulously designed to address the common challenges researchers face when dealing with large sets of data, particularly complex health data. Limmi's Disease Insights Platform offers a suite of tools including advanced AI modeling, comprehensive data integration from all common healthcare data types, collaborative tools for researchers, and real-time analysis of continuous learning from real world data. In the near future, Limmi hopes to use AI with physicians to predict other diseases such as a person's risk of cancer, eventually growing into other areas of healthcare management in the future.